CATALYST PHARMACEUTICALS, INC. Quarterly Income Tax Expense (Benefit) in USD from Q2 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Catalyst Pharmaceuticals, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2013 to Q3 2024.
  • Catalyst Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $13.3M.
  • Catalyst Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $46M, a 145% increase year-over-year.
  • Catalyst Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2023 was $23.1M, a 6.75% increase from 2022.
  • Catalyst Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2022 was $21.6M, a 64.1% increase from 2021.
  • Catalyst Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2021 was $13.2M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $46M $13.3M +$20.6M Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $25.4M $15M +$4.24M +39.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $21.2M $5.81M -$1.93M -24.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $23.1M $11.9M +$4.33M +57.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $18.8M -$7.26M -$10.5M -323% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $29.3M $10.8M +$4.12M +62.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $25.2M $7.75M +$3.53M +83.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $21.6M $7.54M +$4.03M +115% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $17.6M $3.26M -$484K -12.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $18.1M $6.63M +$2.91M +78.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $15.2M $4.22M +$2M +90.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $13.2M $3.5M +$6.22M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $6.97M $3.74M +$35.3M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$28.4M $3.72M +$3.11M +507% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$31.5M $2.22M +$1.61M +264% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$33.1M -$2.71M -$3.19M -670% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-15
Q3 2020 -$29.9M -$31.6M -$32.2M -5295% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $2.31M $613K +$163K +36.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $2.14M $610K +$610K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $1.53M $476K +$476K Oct 1, 2019 Dec 31, 2019 10-K 2022-03-16
Q3 2019 $1.06M $608K +$608K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $450K $450K +$450K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $0 $0 $0 Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-10
Q4 2018 $0 $0 $0 Oct 1, 2018 Dec 31, 2018 10-K 2021-03-15
Q3 2018 $0 $0 $0 Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-07
Q2 2018 $0 $0 $0 Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $0 $0 $0 Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $0 $0 $0 Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 $0 $0 $0 Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $0 $0 $0 Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $0 $0 $0 Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $0 $0 $0 Oct 1, 2016 Dec 31, 2016 10-K 2018-03-14
Q3 2016 $0 $0 $0 Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $0 $0 $0 Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $0 $0 $0 Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $0 $0 $0 Oct 1, 2015 Dec 31, 2015 10-K 2018-03-14
Q3 2015 $0 $0 $0 Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $0 $0 $0 Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $0 $0 $0 Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $0 $0 Oct 1, 2014 Dec 31, 2014 10-K 2017-03-15
Q3 2014 $0 Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $0 $0 Apr 4, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $0 Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q2 2013 $0 Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.